Superluminal Medicines
2 employees
Biotech
Series A · $158.0M
Open positions (9)
Company details
Team Size2
IndustryBiotech
Funding
Total raised
$158.0M
Last stage
Series A
Investors
NVentures
Total raised
$158.0M
Last stage
Series A
Investors
Cony D'Cruz
Co-founder and CEO of Superluminal Medicines. Previously a Schrödinger alum. Led the company from its origins as a stealth project at RA Capital Management.
Ajay Yekkirala
PhD; former postdoc at Harvard Medical School and Boston Children's Hospital; previously VP, Head of Biology at RA Capital Management; co-founder of Blue Therapeutics.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.